You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

DATSCAN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Datscan, and when can generic versions of Datscan launch?

Datscan is a drug marketed by Ge Hlthcare Inc and is included in one NDA.

The generic ingredient in DATSCAN is ioflupane i-123. Two suppliers are listed for this compound. Additional details are available on the ioflupane i-123 profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Datscan

A generic version of DATSCAN was approved as ioflupane i-123 by CURIUM on March 30th, 2022.

  Try a Trial

Summary for DATSCAN
US Patents:0
Applicants:1
NDAs:1
Finished Product Suppliers / Packagers: 1
Raw Ingredient (Bulk) Api Vendors: 7
Clinical Trials: 17
Patent Applications: 136
What excipients (inactive ingredients) are in DATSCAN?DATSCAN excipients list
DailyMed Link:DATSCAN at DailyMed
Drug patent expirations by year for DATSCAN
Recent Clinical Trials for DATSCAN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
InvicroPhase 1
GE HealthcarePhase 1
PPDPhase 1

See all DATSCAN clinical trials

Pharmacology for DATSCAN

US Patents and Regulatory Information for DATSCAN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ge Hlthcare Inc DATSCAN ioflupane i-123 SOLUTION;INTRAVENOUS 022454-001 Jan 14, 2011 AP RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for DATSCAN

See the table below for patents covering DATSCAN around the world.

Country Patent Number Title Estimated Expiration
Portugal 703791 ⤷  Try a Trial
World Intellectual Property Organization (WIPO) 9639198 ⤷  Try a Trial
Japan 2001515459 ⤷  Try a Trial
Japan H09503745 ⤷  Try a Trial
Japan 3228422 ⤷  Try a Trial
Australia 6159796 ⤷  Try a Trial
Australia 4655493 ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for DATSCAN

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0703791 9/2003 Austria ⤷  Try a Trial PRODUCT NAME: IOFLUPANE (123I); REGISTRATION NO/DATE: EU/1/00/135/001 20000727
0703791 CA 2003 00010 Denmark ⤷  Try a Trial
0703791 SPC/GB03/010 United Kingdom ⤷  Try a Trial PRODUCT NAME: IOFLUPANE (123I) OR (123I)-2-BETA-CARBOMETHOXY-3-BETA-(4-IODOPHENYL)-8-(3-FLUOROPROPYL)-NORTROPANE; REGISTERED: UK EU/1/00/135/001 20000802
0703791 03C0021 France ⤷  Try a Trial PRODUCT NAME: IOFLUPANE (123 I); REGISTRATION NO/DATE: EU/1/00/135/001 20000727
0703791 C300123 Netherlands ⤷  Try a Trial PRODUCT NAME: IOFLUPANE (123I); NAT. REGISTRATION NO/DATE: EU/1/00/135/001 20000727; FIRST REGISTRATION: EU/1/00/135/001 20000727
0703791 300123 Netherlands ⤷  Try a Trial
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.